Friedreich’s Ataxia News
The team at Friedreich’s Ataxia News helped spread the word about Retrotope’s recent rare pediatric disease designation and Fast Track designation for RT001 in FA. Our pivotal Phase 2/3 trial of RT001 in FA is fully enrolled and we expect data from the study by the end of 2021.
https://friedreichsataxianews.com/news-posts/2021/03/04/rt001-fda-rare-pediatric-disease-fast-track-designation-friedreichs-ataxia/